ADVERSE SIDE EFFECTS WITH PERFLUOROHEXYLOCTANE AS A LONG-TERM TAMPONADE AGENT IN COMPLICATED VITREORETINAL SURGERY

Background: To report long-term intraocular tolerance of perfluorohexyloctane (F6H8). Methods: F6H8 was used as an endotamponade in 18 patients (9 male and 9 female) with a median age of 65 years (range, 14–82 years) and complicated pathologic conditions of the inferior fundus: rhegmatogenous retinal detachment (17 patients) and tractional retinal detachment owing to proliferative diabetic retinopathy (1 patient). In six eyes, additional proliferative vitreoretinopathy was present. The use of F6H8 was primary in 2 patients, and 16 patients had had previous retinal detachment surgery (median number, 2). F6H8 was left in the eye for a median duration of 8 weeks (range, 2–14 weeks). Results: The median follow-up period was 6 months (range, 3–18 months). Permanent reattachment was achieved in 10 (56%) eyes after removal of F6H8. In 8 (44%) of 18 eyes, a redetachment occurred. Two eyes became phthisic. Adverse side effects included photophobia in two patients, pain in two, hypotony in four, early emulsification in one, corneal lesion in one, fibrinous membranes in five, posterior lens opacification in one, and retinal scar formation in one. Conclusion: Perfluorohexyloctane provides good support to the inferior retina. Because of numerous adverse side effects, it should be considered carefully when used as a long-term tamponade. Early removal may reduce the number of side effects.

[1]  D. Wong,et al.  Contact angles of substances used for internal tamponade in retinal detachment surgery , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  F. Bottoni,et al.  Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  B. Kirchhof,et al.  Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal , 2004, International Ophthalmology.

[4]  V. Gabel,et al.  Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[5]  K. Engelmann,et al.  Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[6]  Guoming Zhang,et al.  [An experimental study on effect of perfluorohexyloctane on corneal endothelial cells]. , 2002, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[7]  Bernd Kirchhof,et al.  Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. , 2002, American journal of ophthalmology.

[8]  V. Gabel,et al.  New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  P. Versura,et al.  The Biocompatibility of Silicone, Fluorosilicone and Perfluorocarbon Liquids as Vitreous Tamponades , 2001, Ophthalmologica.

[10]  N. Lois,et al.  Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade , 2001, The British journal of ophthalmology.

[11]  P. Wiedemann,et al.  Flüssige Perfluorkarbone in der Glaskörper- und Netzhautchirurgie , 2000, Der Ophthalmologe.

[12]  I. Grierson,et al.  Biomaterials used in the posterior segment of the eye. , 2000, Biomaterials.

[13]  B. Kirchhof,et al.  Silicone oil removal from a silicone intraocular lens with perfluorohexyloctane. , 2000, Journal of cataract and refractive surgery.

[14]  N. Lois,et al.  Perfluorocarbons and Semifluorinated Alkanes , 2000, Seminars in ophthalmology.

[15]  S. Yamamoto,et al.  Silicone Oil and Fluorosilicone , 2000, Seminars in ophthalmology.

[16]  P. Wiedemann,et al.  [Perfluorocarbon liquids in surgery of the vitreous body and retina]. , 2000, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[17]  H. Meinert,et al.  Semifluorinated Alkanes – A New Class of Compounds with Outstanding Properties for use in Ophthalmology , 2000, European journal of ophthalmology.

[18]  B. Kirchhof,et al.  A new way of removing silicone oil from the surface of silicone intraocular lenses , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[19]  R. Pflug,et al.  Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results. , 1997, Retina.

[20]  S. Binder,et al.  Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications. , 1995, The British journal of ophthalmology.

[21]  G. Peyman,et al.  Perfluorocarbon liquids in ophthalmology. , 1995, Survey of ophthalmology.

[22]  G. Peyman,et al.  An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Vitreon Collaborative Study. , 1995, Ophthalmic surgery.

[23]  M. Refojo,et al.  Histopathology of rabbit eyes with intravitreous silicone-fluorosilicone copolymer oil. , 1994, Experimental eye research.

[24]  G. Peyman,et al.  Perfluoroperhydrophenanthrene (Vitreon) as a short-term vitreous substitute after complex vitreoretinal surgery. , 1993, Ophthalmic surgery.

[25]  M. Refojo,et al.  Ocular toxicity of low-molecular-weight components of silicone and fluorosilicone oils. , 1991, Investigative ophthalmology & visual science.

[26]  C. Eckardt,et al.  EXPERIMENTAL INTRAOCULAR TOLERANCE TO LIQUID PERFLUOROOCTANE AND PERFLUOROPOLYETHER , 1991, Retina.